top of page
Search


Building the Case for a Therapeutic Asset
Lessons from BioAsia Taiwan 2026 and recent research on how biology and evidence shape drug development decisions Key Takeaways AI drug discovery is moving beyond molecule generation. Recent work increasingly extends AI into target assessment, experimental planning, data interpretation, clinical development, and scientific decision support. Model performance matters when it changes a development decision. Predictive accuracy has value when it helps teams generate more releva
Esther Chen
12 hours ago9 min read
bottom of page